 | Up a level |
Thormann, Kathrin; Lüthi, Anne-Sophie; Deniau, Felix; Heider, Anja; Cazzaniga, Simone; Radonjic-Hoesli, Susanne; Lehmann, Mathias; Schlapbach, Christoph; Herzog, Elio L; Kreuzer, Marco; Zinkernagel, Martin S; Akdis, Cezmi A; Zysset, Denise C; Simon, Hans-Uwe; Simon, Dagmar (2024). Dupilumab-associated ocular surface disease is characterized by a shift from Th2/Th17 toward Th1/Th17 inflammation. Allergy, 79(4), pp. 937-948. Wiley-Blackwell 10.1111/all.16045
Bürgler, Christina; Dutoit, Danielle; Radonjic-Hoesli, Susanne; Thormann, Kathrin; Lehmann, Mathias; Yousefi, Shida; Simon, Hans-Uwe; Simon, Dagmar (2024). Dupilumab normalizes correlates of lysosomal function in atopic dermatitis. JEADV Clinical Practice, 3(2), pp. 478-486. Wiley 10.1002/jvc2.307
Guex-Crosier, Yan; Di-Lucca, Julie; Häusermann, Peter; Laffitte, Emmanuel; Saulite, Ieva; Schmid-Grendelmeier, Peter; Schürch, Kaspar; Thormann, Kathrin; Simon, Dagmar (2021). Management of dupilumab-associated ocular surface diseases in atopic dermatitis patients. Swiss medical weekly, 151, w30020. EMH Media 10.4414/SMW.2021.w30020
Rohner, Maria Helena; Thormann, Kathrin; Cazzaniga, Simone; Yousefi, Shida; Simon, Hans-Uwe; Schlapbach, Christoph; Simon, Dagmar (2021). Dupilumab reduces inflammation and restores the skin barrier in patients with atopic dermatitis. Allergy, 76(4), pp. 1268-1270. Wiley-Blackwell 10.1111/all.14664
